BBA

Baker Bros. Advisors Portfolio holdings

AUM $13.8B
1-Year Est. Return 85.12%
This Quarter Est. Return
1 Year Est. Return
+85.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.04B
AUM Growth
-$325M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
99
New
Increased
Reduced
Closed

Top Buys

1 +$64.1M
2 +$28.5M
3 +$24M
4
PCVX icon
Vaxcyte
PCVX
+$22.4M
5
CELC icon
Celcuity
CELC
+$16M

Top Sells

1 +$199M
2 +$26.6M
3 +$25.4M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$22.3M
5
AKRO icon
Akero Therapeutics
AKRO
+$22.2M

Sector Composition

1 Healthcare 98.87%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$2.39B 26.5%
8,799,053
-732,827
2
$1.86B 20.6%
30,739,953
+487
3
$712M 7.88%
42,877,916
4
$654M 7.24%
1,974,590
5
$471M 5.21%
24,424,865
6
$410M 4.54%
5,380,626
+373,763
7
$297M 3.29%
5,604,483
-479,766
8
$281M 3.11%
7,936,972
9
$164M 1.82%
5,995,929
10
$148M 1.64%
4,483,285
+301,534
11
$135M 1.5%
6,155,940
12
$108M 1.19%
11,045,336
13
$93.3M 1.03%
5,457,881
+3,750,000
14
$92.4M 1.02%
10,885,357
15
$68.9M 0.76%
2,322,656
+807,338
16
$62.6M 0.69%
2,818,323
17
$61.4M 0.68%
27,525,640
18
$57.1M 0.63%
1,576,114
19
$50.7M 0.56%
3,731,695
20
$48.6M 0.54%
17,310,490
21
$46.1M 0.51%
3,882,125
22
$46M 0.51%
77,760
-34,144
23
$44M 0.49%
4,865,819
24
$43M 0.48%
4,257,735
+1,579,182
25
$41.6M 0.46%
1,630,125